House GOP Pursues ACA Subsidy Alternatives as Deadline Nears

Congress is nearing a deadline without resolving the impending expiration of enhanced tax subsidies for Affordable Care Act (ACA) plans, set to end December 31. The Senate failed to advance both Republican and Democratic health care proposals this week, shifting the focus to the House of Representatives to develop a solution. House Speaker Mike Johnson and Republican leaders are working on an alternative that would not extend ACA tax credits but instead expand health savings accounts (HSAs) and association health plans (AHPs). These plans allow small businesses and self-employed individuals to group together for coverage but are criticized for offering less comprehensive benefits than ACA plans. President Trump has promoted an approach involving direct stipends to individuals to help with insurance costs, diverging from subsidy extensions. The Senate GOP's failed proposal partly aligned with this vision by proposing annual payments to health savings accounts. Meanwhile, the Republican caucus remains divided, with some centrist members seeking to preserve subsidies to prevent premium spikes for millions currently enrolled in ACA coverage. Centrists have filed bipartisan discharge petitions aiming to force floor votes on temporary subsidy extensions—ranging from one to two years—and include provisions to combat marketplace fraud and regulate pharmacy benefit managers (PBMs). PBMs, which administer prescription benefits and negotiate drug prices, face scrutiny for practices that may disadvantage independent pharmacies and inflate costs. Democratic leaders support a separate discharge petition advocating a clean three-year subsidy extension, which lacks Republican support and faces Senate opposition. The split between the parties reflects broader challenges in reaching consensus on health care policy ahead of the current enhanced subsidies expiration. This impasse presents risks for millions of ACA enrollees, many of whom will face significant premium increases if subsidies lapse without replacement measures. As the congressional session concludes, the lack of agreement underscores ongoing complexities in reconciling cost, coverage, and regulatory issues in the U.S. health insurance market.